As of January 2025, integrating AI into healthcare remains a tightrope walk. Only 25% of US healthcare execs embraced generative AI by December 2023, while a whopping 75% of patients remain skeptical. AI's promise in oncology is shadowed by issues like data fragmentation and bias—ChatGPT even misdiagnosed 83% of pediatric cases! EU’s AI Act demands rigorous oversight, but high costs and lack of standards keep many institutions cautious. Will AI prove its worth or remain a costly companion?